US 12398154
Azaquinazoline pan-KRas inhibitors
granted A61PA61P35/00
Quick answer
US patent 12398154 (Azaquinazoline pan-KRas inhibitors) held by Mirati Therapeutics, Inc. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61P, A61P35/00